Here, we performed a hypothesis-driven case-control study to evaluate the impact of gene variations of MTNR1A and MTNR1B on the risk and progression of HCC and observed an association of melatonin receptor gene polymorphisms with the risk of HCC, liver cancer metastasis, and augmented liver damage. The gene discussed is MTNR1B; the disease is hepatocellular carcinoma.